Pyrimido[5,4-d]pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents

A Lopes, N Santarém, A Cordeiro-da-Silva… - ACS Medicinal …, 2022 - ACS Publications
Sleeping sickness and leishmaniasis are neglected tropical diseases that threaten millions
of people. The currently available therapies present several limitations, including high …
被引用次数：4 相关文章
[HTML] nih.gov

[HTML][HTML] Pyrimido [5, 4-d] pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents

A Lopes, N Santarém, A Cordeiro-da-Silva… - ACS Medicinal …, 2022 - ncbi.nlm.nih.gov
Sleeping sickness and leishmaniasis are neglected tropical diseases that threaten millions
of people. The currently available therapies present several limitations, including high …

Pyrimido [5, 4-d] pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents

A Lopes, N Santarém… - ACS medicinal …, 2022 - pubmed.ncbi.nlm.nih.gov
Sleeping sickness and leishmaniasis are neglected tropical diseases that threaten millions
of people. The currently available therapies present several limitations, including high …

Pyrimido[5,4-d]pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents.

A Lopes, N Santarém, A Cordeiro-da-Silva… - ACS Medicinal …, 2022 - europepmc.org
Sleeping sickness and leishmaniasis are neglected tropical diseases that threaten millions
of people. The currently available therapies present several limitations, including high …

Pyrimido[5,4-d]pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents.

A Lopes, N Santarém, A Cordeiro-da-Silva… - ACS Medicinal …, 2022 - europepmc.org
Sleeping sickness and leishmaniasis are neglected tropical diseases that threaten millions
of people. The currently available therapies present several limitations, including high …